Gerard Hanna

Queen's University Belfast

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (5)

Karl T. Butterworth

UNITED KINGDOM

View details

John O'Connor

The Queen's University Belfast

UNITED KINGDOM

View details

Mihaela Ghita-Pettigrew

The Queen's University Belfast

UNITED KINGDOM

View details

Yu Yang Soon

University of Sydney

AUSTRALIA

View details

Gerard Walls

Queen's University Belfast

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gerard Hanna

Research Interests

Explore related searches

Contact this professor

Articles (10)

Should radiation dose be personalized in patients with localized NSCLC and actionable genetic alterations? Insight from a multicenter real-world study

Quality Indicators and Benchmarks for Radiotherapy in Lung Cancer: A Modified Delphi Approach

Pulmonary vein dose and risk of atrial fibrillation in patients with non-small cell lung cancer following definitive radiotherapy: an NI-HEART analysis

PTEN Depletion Increases Radiosensitivity in Response to Ataxia Telangiectasia-Related-3 (ATR) Inhibition in Non-Small Cell Lung Cancer (NSCLC)

In reply to Craig et al.

Radiation Oncology Opinions and Practice on Cardiotoxicity in Lung Cancer: A Cross-sectional Study by the International Cardio-oncology Society

Baseline cardiac parameters as biomarkers of radiation cardiotoxicity in lung cancer: an NI-HEART analysis

SBRT for oligoprogressive disease: using the evidence to maximise the benefits

The Association of Incidental Radiation Dose to the Heart Base with Overall Survival and Cardiac Events after Curative-intent Radiotherapy for Non-small Cell Lung Cancer: Results from the NI-HEART Study

SBRT for oligoprogressive disease: using the evidence to maximise the benefits.

Collaborators (5)

Karl T. Butterworth

John O'Connor

Mihaela Ghita-Pettigrew

Yu Yang Soon

Gerard Walls

Make your next move.